MK

Mike Kramer

Venture Partner at Vensana Capital

Santa Rosa, California

Investor
VC

Invests in

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $40,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Surgery
Medicine
Medical Devices
Venture Capital
Acquisition Integration
Start-ups
Financial Analysis
Mergers
Forecasting
Finance
Financial Modeling
Cross-functional Team Leadership
Sarbanes-Oxley Act
CFOs
Due Diligence
Mergers & Acquisitions
Leadership
SEC filings
Private Equity
Executive Management

Education

Work Experience

Vensana Capital

2021

  • Partner

    2024

  • Venture Partner

    2021 - 2023

MedAvail, Inc.

2020 - 2024

  • Board Member, Audit Committee Chair and Member of Compensation Committee

    2020 - 2024

CRG LP

2017 - 2021

  • Operating Partner

    2017 - 2021

Benvenue Medical

2018 - 2020

  • Member of the Board of Directors

    2018 - 2020

Endologix, Inc.

2016 - 2017

  • Chief Operating Officer, Santa Rosa

    2016 - 2017

TriVascular

2010 - 2016

  • Chief Financial Officer

    2010 - 2016

    Cardiovascular device manufacturer focused on treatment of abdominal aortic aneurysms. Successfully completed a $91 million initial public offering in April 2014. Sold to Endologix in February 2016 for approximately $211 Million.

ATS Medical, Inc.

2006 - 2010

  • Chief Financial Officer

    2006 - 2010

    Public cardiovascular device manufacturer providing solutions for heart valve disease and atrial fibrillation. Sold to Medtronic in August 2010 for approximately $375 Million.

CABG Medical, Inc.

2005 - 2006

  • Controller

    2005 - 2006

    Public cardiac surgery company developing an artificial bypass graft for CABG surgery.

Ecolab

2004 - 2005

  • Manager, Financial Analysis

    2004 - 2005

Ernst & Young

2001 - 2004

  • Manager, Assurance and Advisory Services

    2001 - 2004